MiRNAs can bind to and inhibit mRNA expression.17 To further understand the mechanism of miR‐1182 in prostate cancer progression, the binding partner of miR‐1182 was predicted, and results showed that miR‐1182 may bind to FOXP4 mRNA (Figure 5A). The gene discussed is FOXP4; the disease is prostate carcinoma.